Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More
09/09/2024
Details Of Shares Dematerialized During August 2024Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018
Please find enclosed herewith the details of shares dematerialised during the mo...Read More
06/09/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith copies of newspaper advertisement regarding Notice...Read More
06/09/2024
Intimation Of Book Closure Of Annual General Meeting
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requir...Read More
05/09/2024
Business Responsibility and Sustainability Reporting (BRSR)
Pursuant to the provisions of Regulation 34(2)(f) of the SEBI (Listing Obligatio...Read More
05/09/2024
Intimation Of 40Th Annual General Meeting (AGM) Of The Company Scheduled To Be Held On Friday September 27 2024 At 11:30 A.M. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OAVM)
Please find enclosed Notice of 40th AGM and the Annual Report for the financial ...Read More
05/09/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requir...Read More
26/08/2024
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations)
We would like to inform you that the Company has received a Demand Order dated A...Read More
20/08/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith newspaper copies of the Extract of Statement of Un...Read More
16/08/2024
Disclosure Of Audit Committee Views On Resignation Of The Statutory Auditors Of The CompanyS Material Subsidiary Panacea Biotec Pharma Limited
We would like to inform you that the Audit Committee of the Company in its meeti...Read More
14/08/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached Press Release on initiation of Phase III Clinical Trial of ...Read More
14/08/2024
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
The Board of Directors at its meeting held today i.e. August 14 2024 recommende...Read More
14/08/2024
Re-Classification From Promoter & Promoters Group Category To Public Category Of Panacea Biotec Limited
Please find attached disclosure under regulation 30 of SEBI LODR Regulations reg...Read More
14/08/2024
Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended 30.06.2024
Please find attached Standalone and Consolidated Unaudited Financial Results for...Read More
14/08/2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 14 2024
Please find attached Outcome of Board Meeting held on August 14 2024
14/08/2024
Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of Request Seeking Re-Classification From Promoter And Promoters Group Category To Public Category Of Panacea
We hereby inform that the Company has received request letters on 07.08.2024 fro...Read More
07/08/2024
Demat Report For The Month Of July 2024
Please find attached herewith the details of shares dematerialised during July 2...Read More
07/08/2024
Board Meeting Intimation for For Approving Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter Ended June 30 2024
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors o...Read More
02/08/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Please find attached certificate dated July 02 2024 issued by Skyline Financial ...Read More
05/07/2024
Demat Status Report For The Month Of June 2024
Please find attached details of shares dematerialized during June 2024 under Reg...Read More
